Magnetic resonance spectroscopy analysis of intramyocellular lipid composition in lipodystrophic patients and athletes by Savage, David et al.
1 
 
Accumulation of saturated intramyocellular lipid is associated with insulin resistance 
 
David B Savage 1, Laura Watson 2, Katie Carr 2, Claire Adams 1, Soren Brage 3, Krishna K Chatterjee 1,2, 
Leanne Hodson 4, Chris Boesch 5, Graham J Kemp 6, Alison Sleigh 1,2,7  * 
 
 
1 Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Cambridge 
Biomedical Campus, Cambridge, United Kingdom. 
2 National Institute for Health Research/Wellcome Trust Clinical Research Facility, Cambridge University 
Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom. 
3 MRC Epidemiology Unit, University of Cambridge, School of Clinical Medicine, Cambridge, United 
Kingdom. 
4 Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Radcliffe Department of 
Medicine, University of Oxford, Oxford, United Kingdom. 
5 Department of Clinical Research and Radiology, AMSM, University Bern, Bern, Switzerland. 
6 Department of Musculoskeletal Biology, University of Liverpool and MRC–Arthritis Research UK 
Centre for Integrated research into Musculoskeletal Ageing (CIMA), Liverpool, United Kingdom. 
7 Wolfson Brain Imaging Centre, University of Cambridge School of Clinical Medicine, Cambridge, 
United Kingdom. 
 
* Corresponding author: A. Sleigh, Box 65 Addenbrooke’s Hospital, Hills Road, Cambridge, CB2 0QQ, 
United Kingdom. Phone. 44.1223.746.460; Email. as626@cam.ac.uk 
Short running title: IMCL composition and insulin sensitivity 
Abbreviations:    CH2, methylene protons resonating at 1.3 ppm; CH3, methyl protons resonating at 0.9 
ppm; CH2:CH3 ratio, compositional saturation index; EMCL, extramyocellular lipid; HOMA-IR, 
Homeostatic Model Assessment of Insulin Resistance; IMCL, intramyocellular lipid; LD, lipodystrophic; 
MRS, magnetic resonance spectroscopy; SOL, soleus; TA, tibialis anterior; VO2max, maximal oxygen 
consumption.    
 by guest, on O
ctober 7, 2019
w
w
w
.jlr.org
D
ow
nloaded from
 
2 
 
Abstract 
Intramyocellular lipid (IMCL) accumulation has been linked to both insulin-resistant and to insulin-
sensitive (athletes) states. Biochemical analysis of intramuscular triglyceride composition is confounded 
by extramyocellular triglyceride in biopsy samples, and hence the composition of specifically IMCL is 
unknown in these states. 1H magnetic resonance spectroscopy can overcome this, and we used a recently 
validated method to compare the compositional saturation index (CH2:CH3 ratio) and concentration 
independent of composition (CH3) of IMCL in the soleus and tibialis anterior muscles of 16 female 
insulin-resistant lipodystrophic subjects with that of age- and gender-matched athletes (n=14) and healthy 
controls (n=41). The IMCL CH2:CH3 ratio was significantly higher in both muscles of the lipodystrophic 
subjects compared with controls, but was similar in athletes and controls. IMCL CH2:CH3 was dependent 
on IMCL concentration in the controls, and after adjusting the composition index for quantity 
(CH2:CH3adj) was able to distinguish lipodystrophics from athletes. This CH2:CH3adj marker had a stronger 
relationship with insulin resistance than IMCL concentration alone, and was inversely related to VO2max. 
The association of insulin resistance with accumulation of saturated IMCL is consistent with (a) a 
potential pathogenic role for saturated fat, and (b) the reported benefits of exercise and diet in insulin 
resistant states.  
 
Keywords: 
Triglycerides; fatty acids; lipodystrophies; spectroscopy; lipid composition; muscle; exercise; in vivo.  
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Introduction 
Following the demonstration that 1H magnetic resonance spectroscopy (1H MRS) can noninvasively 
distinguish intramyocellular (IMCL) from extramyocellular (EMCL) lipids (1, 2), associations were 
reported between soleus IMCL accumulation and insulin resistance (IR) independent of fat mass (3–5). 
Given that skeletal muscle represents the primary site for postprandial glucose disposal (6), these findings 
were of considerable physiological interest. Furthermore these data strongly supported the link between 
ectopic fat accumulation and insulin resistance (7, 8). Although it soon became clear that triglycerides 
themselves were unlikely to be involved in causing IR, intramuscular triglyceride content does appear to 
correlate with insulin resistance in some states (5, 9–12). One particularly striking and surprising 
exception was reported in athletes, where histological studies suggested that neutral lipid accumulation 
was a feature of skeletal muscle in insulin-sensitive trained athletes (13, 14), and this has led to the now 
widely cited notion of an ‘athlete’s paradox’ (13). This concept is consistent with the idea that triglyceride 
itself is not casually involved in IR and has prompted several efforts to identify the lipid intermediates 
responsible for causing IR or preserving the insulin sensitivity of athletes. 
Saturated fat has been implicated in the pathogenesis of metabolic disease (15, 16) and we have recently 
described and validated (using IMCL/EMCL simulated phantoms of known composition) a 1H MRS 
method that provides an in vivo compositional marker of IMCL that primarily reflects the degree of 
saturation of the fatty acid chains within triglyceride (17). This marker, which we call the ‘IMCL 
saturation index’ (CH2:CH3), utilizes good quality spectra acquired at 3T with short echo time and 
compares the CH2 resonance located at 1.3 ppm (which is influenced by both concentration and 
composition), with that of the CH3 resonance at 0.9 ppm (which is independent of triglyceride 
composition): this is illustrated in Figure 1. From this figure it can also be seen that using concentration of 
‘H’ that resonate at 1.3 ppm (CH2) to represent the concentration of lipid without knowledge of the 
underlying composition, as has been the practice in virtually all published 1H MRS studies of IMCL so 
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far, confounds the contributions of both the concentration of lipid and its composition. This has potential 
for significant error in the estimation of concentration: the composition would contribute as much as 50% 
to the observed signal (equivalent to a 100% theoretical increase in signal) if the pool was stearic acid 
instead of linoleic acid. We therefore use the IMCL CH3 peak at 0.9 ppm to estimate the total 
concentration of IMCL, as this is independent of the degree of saturation of the fatty acid chains within 
triglyceride (i.e. composition). We call this the composition-independent IMCL concentration estimate, to 
distinguish it from the conventional estimate using CH2. 
Lipodystrophy is a rare cause of severe IR and is typically characterized by prominent ectopic fat 
accumulation due both to the reduction in adipocyte lipid storage capacity and the associated hyperphagia 
induced by leptin deficiency. In order to ascertain if intramyocellular lipid composition is altered in 
lipodystrophic (LD) subjects, and if such changes in lipid composition might help to elucidate the 
‘athlete’s paradox’, we determined the compositional saturation index (CH2:CH3 ratio) and composition-
independent concentration (from CH3) of IMCL in the soleus and tibialis anterior muscles of female 
insulin-resistant lipodystrophic subjects, as well as age- and gender-matched athletes and non-athlete 
controls.  
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Materials and Methods 
Participants  
Sixteen female subjects with lipodystrophy were identified as part of a long-standing study of human IR 
syndromes, while age- and gender-matched controls (n=41) and athletes (n=14) were recruited by 
advertisement. Soleus IMCL data from five of the subjects were included in a previously published study 
(18). Control and athlete exclusion criteria included smoking, drug or alcohol addiction, any current or 
past medical disorder or medications that could affect measurements including supplements such as 
creatine, and standard MR contraindications. Controls were recruited who exercised less than 3 times per 
week for 1 hour each time, whilst the athletes were part of a running club, some at international level, and 
all ran distances between 10 and 40 km regularly. Subjects with lipodystrophy were recruited if they could 
perform an overnight fast without insulin or a rapid-acting insulin analogue. The studies relating to 
lipodystrophy were approved by the National Health Service Research Ethics Committee and the healthy 
volunteer studies by East of England Cambridge Central Ethics Committee. Studies were conducted in 
accordance with the Declaration of Helsinki and all participants provided written informed consent.     
Protocol 
Volunteers were instructed to follow normal dietary habits for 3 days prior to arrival at the Cambridge 
NIHR/Wellcome Trust Clinical Research Facility. Participants provided fasting blood samples and were 
given a light breakfast of either toast or cereal immediately prior to 1H MRS at 09:30. Athletes were 
instructed to refrain from vigorous exercise for at least 24 hours and controls 19 hours prior to 1H MRS.  
HOMA-IR was calculated as fasting insulin (pmol/l)*fasting glucose (μU/ml) / 22.5. Body composition 
was assessed by Dual-energy X-ray Absorptiometry (GE Lunar Prodigy encore v12.5 or GE Lunar iDXA 
encore v16 (athletes).  
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1H Magnetic Resonance Spectroscopy (1H MRS) 
1H MRS studies were performed on a Siemens 3T scanner (Erlangen, Germany) using the Point 
RESsolved Spectroscopy (PRESS) sequence with short echo time of 35 ms. A water-suppressed 1H 
spectrum was acquired from a voxel of cube length 1.3 cm positioned to avoid visible fat on T1-weighted 
images within TA and SOL, using a 5 s repetition time and 64 averages (non-water-suppressed spectrum 4 
averages). Data were analysed in jMRUI (19, 20) and fitted with the AMARES (21) algorithm using 
identical prior knowledge parameters: Gaussian lineshapes (except water: Lorentzian), soft constraints on 
EMCL/IMCL CH2 frequencies and linewidths, CH3 resonant frequencies and linewidths determined from 
known and inferred prior knowledge relative to the CH2 resonance (22), and with all amplitudes estimated. 
As the CH3 resonance is small and may be subject to spectral overlap, the results were later checked for 
robustness by reanalysing the data using different fitting parameters as outlined in Supplemental Table S1 
(upper). IMCL CH2 and CH3 are quantified relative to the methyl group of creatine plus phosphocreatine 
at 3.0 ppm (Cr). As this resonance exhibits different lineshape characteristics in the tibialis anterior and 
soleus muscles (23), comparable quantification between muscles using a nominal concentration of muscle 
creatine is not valid; instead a scaling factor of Cr to water signal for each muscle was established from a 
subset of participants who had non-water-suppressed datasets, yielding a calculated water signal (water-
calc). Absolute composition-independent IMCL concentrations in mmol/kg muscle wet weight (ww) were 
calculated from the compositionally invariant CH3 IMCL resonance, with standard assumptions regarding 
muscle water content, and correction for T2 relaxation effects, J coupling and proton density as outlined 
below. 
Absolute IMCL concentrations in mmol/kg muscle wet weight were calculated using the CH3 IMCL 
resonance (which is compositionally invariant) using the following equation. 
[IMCL] = (So IMCL CH3 / So water-calc) . [water]        (Eq. 1) 
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where So is the corrected signal intensity of the resonance, water-calc is the calculated water signal from 
the internal standard (creatine and phosphocreatine), and [water] is the concentration of water in skeletal 
muscle (calculated using a pure water concentration of 55342 mmol/L and assuming a relative tissue water 
content in human skeletal muscle of 0.81 (kg/kg) and tissue density of 1.05 g/ml (24)). As the IMCL CH3 
resonance is subject to J-coupling effects and has an unknown T2 relaxation time we utilised the ratio of 
theoretical-to-measured IMCL CH3:CH2 which would take into effect both J-coupling and T2 effects at 
this echo time as well as any bias of constrained fitting prior knowledge of the CH3 resonance.  
(So IMCL CH3 / So water-calc) = (So IMCL CH3 / So IMCL CH2) . (So IMCL CH2 / So water-calc)  (Eq. 2) 
Therefore, 
 (So IMCL CH3 / So water-calc) = (S IMCL CH3 /S water-calc).(GTM CH3:CH2).(T2corr CH2/water).(n water:IMCL CH3)  
where S is the uncorrected signal intensity of the resonance. (GTM CH3:CH2) = 1.1966 and is the gradient of 
the line of best fit through the origin of the graph of theoretical-to-measured  CH3:CH2 in vitro in IMCL 
and EMCL simulated phantoms using the PRESS sequence at 3T with a TE = 35 ms with the same fitting 
(17), under the assumption J-coupling and T2 relaxation effects would be similar to in vivo. (T2corr CH2/water) 
is the correction factor for T2 effects of CH2 and water which was calculated using accepted T2 values at 
3T for each muscle (25), and (n water:IMCL CH3) the correction for proton density. 
The IMCL saturation index (CH2:CH3) was calculated as IMCL CH2/CH3, and the IMCL saturation index 
adjusted for quantity (CH2:CH3adj) = CH2 – (mCH3 + c), where m and c are the gradient and intercept of 
the regression line through the control data points of CH2 vs CH3. Investigators were blind to the insulin 
resistance status of the participants during 1H MRS analysis.  
Assessment of VO2max 
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Participants underwent continuous incremental exercise testing to 85% age-predicted maximum heart rate 
(controls) or volitional exhaustion (athletes) on a treadmill (Trackmaster TMX425, Med-electronics, MD). 
Lipodystrophic subjects did not perform an exercise test.  Oxygen consumption was measured using a 
spiro-ergometer (Medical Graphics UK Ltd and Breezesuit ® Gas exchange software). For the control 
participants a standard incremental protocol was performed (26), while the athletes undertook a protocol 
that began with a 10 min warm-up period at each participant’s preferred warm-up running speed, 
following which the test was initiated at 9 km/hr and increased steadily (0.74 km.hr-1.min-1), with a ramp 
at 5 minutes (increasing 0.5 % every 15s) until exhaustion or a plateaux in VO2 was apparent. In controls 
VO2max was calculated by extrapolating the submaximal heart rate – VO2 relationship to age- predicted 
maximum heart rate (27).  
Statistics  
All statistics were performed in IBM SPSS Statistics 24 (IBM, Armonk, NY: IBM Corp.) with 
significance set at P < 0.05. Normality was assessed by the Shapiro-Wilk test and non-normally 
distributed data were log-transformed prior to statistical testing. ANOVA with Games-Howell post hoc 
analysis was used to compare means between groups, and Pearson’s correlation coefficient for analyzing 
associations. Due to the non-normality of LN(HOMA-IR), IMCL associations with HOMA-IR were 
assessed by Spearman’s rank correlation coefficient. Data are mean ± SEM. 
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Results  
Participants  
Of the insulin-resistant subjects with lipodystrophy 13 had partial forms (8 subjects with FPLD2 due to 
LMNA mutations, 5 subjects with FPLD3 due to PPARG mutations), and 3 generalized lipodystrophy 
(GLD, 2 subjects with an acquired form – AGLD, and 1 due to mutations in the PCYT1A gene (28)). Of 
the LD subjects, 2 were taking no medication at all, 8 were prescribed metformin, 3 were taking statins, 5 
fibrates, and 5 were taking long-acting insulin analogues. The age- and gender-matched controls had a 
wide range of BMI (19.6 – 35.6 kg.m-2) and HOMA-IR (0.3 – 4.9). As a group, insulin and HOMA-IR 
were significantly higher in the LD subjects and lower in the athletes (Table 1) compared with controls, as 
expected. Fat mass and percentage body fat were similar between LD subjects and athletes, which were 
both lower compared to controls (Table 1). Serum triglycerides were higher whilst high-density 
lipoprotein (HDL)-cholesterol concentrations were lower in the LD subjects (Table 1) compared to either 
controls or athletes. EMCL was absent in the 2 subjects with AGLD (Figure 2), but those with partial 
forms of lipodystrophy had EMCL such that overall LD subjects’ EMCL was similar to both controls and 
athletes (Table 1) 
1H MRS analysis of intramyocellular lipid concentration 
In the soleus muscle intramyocellular lipid concentrations derived from the IMCL CH3 peak (0.9 ppm) 
(composition-independent IMCL concentrations) were not significantly increased (p = 0.477) in the LD 
subjects compared to controls, but were higher compared to the lean athletes (p = 0.003) (Figure 3A). In 
the more glycolytic tibialis anterior muscle, composition-independent IMCL concentrations were similar 
in all three groups (Figure 3B). We also observed linear inverse correlations of VO2max and IMCL 
concentration in the subset of controls who underwent VO2max testing and athletes together (Figures 3C & 
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D). Soleus IMCL was significantly lower in the athletes compared to the controls (p = 0.004, Figure 3A) 
and this remained significant (p = 0.025) compared to a subset of the controls matched for percentage 
body fat (body fat = 21.5±2.3 %, n = 10; vs athletes 21.1±1.8 %, n = 14; see Supplemental Figure S1).  
The conventional estimate of IMCL concentration using the CH2 resonance uncorrected for composition, 
CH2/water, showed similar trends to the composition-independent estimate using the CH3 peak with the 
exception that the LD subjects’ soleus IMCL CH2 was significantly increased compared to controls (Table 
1). This could be regarded as an artefact of the effects of compositional differences, which we consider 
next. 
1H MRS analysis of intramyocellular lipid composition 
IMCL had a significantly higher saturation index (CH2:CH3) in both muscles of the lipodystrophic 
subjects compared to controls (soleus p = 0.008, tibialis anterior p = 0.024), but not athletes (Figures 4A & 
B). In the control group, smaller IMCL pools were associated with a higher saturation index, as shown by 
the linear regression line (dotted line in Figures 3 E & F) having a gradient (ΔCH2/ΔCH3) < the mean 
CH2:CH3 (e.g. gradient soleus = 6.7 vs mean CH2:CH3 = 8.8; gradient tibialis anterior = 4.2 vs mean 
CH2:CH3 = 6.0). This phenomenon appeared to be independent of insulin sensitivity in the controls (Table 
2: there was no relation of HOMA-IR with IMCL concentration). To generate a pathophysiologically 
meaningful measure of composition that is independent of IMCL quantity, the vertical (CH2) deviation 
from this regression line was measured and taken as a marker of the saturation of the pool that is adjusted 
for quantity, which we term the adjusted saturation index (CH2:CH3adj). This adjusted compositional 
marker was significantly higher in lipodystrophic subjects compared to athletes (soleus p = 0.001, tibialis 
anterior p = 0.046) and also compared to controls (soleus p = 0.003) with a tendency in the tibialis anterior 
which just falls short of conventional statistical significance (p = 0.06) (Figures 4C & D).  
 by guest, on O
ctober 7, 2019
w
w
w
.jlr.org
D
ow
nloaded from
 
11 
 
Unlike the uncorrected measure of composition, this adjusted composition also had a significant relation 
to VO2max (Figures 4E & F) within the control subset alone, athletes alone (soleus), and control and 
athletes combined (statistics are given in the figure legend), such that fitter individuals had less saturated 
IMCL for the same absolute quantity of IMCL. VO2max significantly correlated with HOMA-IR in the 
control subset (r = -0.59, p = 0.003, n = 23) and in controls and athletes together (r = -0.53, p = 0.001, n = 
37). Figures 4G & H show the relation of the adjusted composition to HOMA-IR 
Table 2 shows relations of IMCL concentration and composition with insulin sensitivity. 
The saturation index was higher in the soleus muscle compared with the tibialis anterior in all 3 groups. 
This was still the case in the two EMCL-deficient AGLD subjects (P1 soleus CH2:CH3 = 9.5, TA 
CH2:CH3 = 6.3; P2 soleus CH2:CH3 = 11.2, TA CH2:CH3 = 7.1).  
The IMCL relations with HOMA-IR were robust to differing fitting parameters, as shown in Supplemental 
Table S1 (lower).  
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Discussion 
Using a recently validated 1H magnetic resonance spectroscopy method we have compared a 
compositional saturation index (CH2:CH3 ratio) of intramyocellular lipid in the soleus and tibialis anterior 
muscles of female insulin-resistant lipodystrophic subjects with that of age- and gender-matched athletes 
and healthy controls, and shown it to be significantly higher in both muscles compared with controls, but 
not athletes. The finding that smaller IMCL pools in the control group had a relatively higher saturation 
index than larger pools irrespective of insulin sensitivity could possibly explain why the athletes studied 
here, who had small IMCL pools, had a statistically similar composition to lipodystrophic subjects. This 
observed concentration – composition relationship seems physiologically plausible given that more 
unsaturated and shorter-chain FA are preferentially mobilized (17). A similar trend was also visible in a 
previous dataset from both tibialis anterior and soleus muscles of 19 healthy males after an 8 hour fast 
(17). We hypothesize that a person may ‘move’ along a line such as this while performing daily activities, 
and that a measurement of deviation from this relationship may therefore be a more sensitive and specific 
measure of muscle metabolic physiology or pathophysiology. To take this concentration-composition 
dependence into consideration we adjusted the compositional saturation index for concentration 
(CH2:CH3adj), and this marker was able to distinguish between athletes and lipodystrophic subjects in both 
muscles. The strong inverse relation of CH2:CH3adj with VO2max indicates that fitness is associated with 
relatively lower saturation of IMCL, although overall athletes and controls were not statistically different; 
this is similar to results from a biopsy study (29) that demonstrated a comparable percentage saturated 
intramuscular triglyceride in male controls and athletes. Interestingly, previous reports of intramuscular 
triglyceride composition in insulin resistant states (30, 31) yielded no difference in saturation percentage, 
but did reveal a difference in linoleate (31). In these studies intramuscular triglyceride was raised in 
insulin resistant states, and therefore a raised saturation percentage may not be apparent, given the 
composition-concentration relation we found; equally this lack of difference in saturation could also be 
explained by the difference in sampling intramuscular versus intramyocellular pools, as EMCL is 
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generally a significant proportion of intramuscular triglyceride (approximately twice the IMCL pool in our 
healthy cohorts even when voxels were placed to avoid visible marbling on T1 weighted images, Table 1).             
By our measure of composition-independent IMCL (using the CH3 instead of the uncorrected CH2 
resonance) we found that the lipodystrophic subjects’ IMCL concentration was not significantly higher in 
either muscle compared with age-, gender- and BMI-matched controls, but was raised in the soleus 
relative to athletes. There are few reports of IMCL in lipodystrophic subjects, but our findings are in 
agreement with Peterson et al. (32) who, in 3 subjects with generalized lipodystrophy (2 congenital, 1 
acquired), found similar soleus IMCL to 6 age-, BMI- and weight-matched controls. Calf IMCL was also 
lower in a case report of acquired generalized lipodystrophy (33) compared to controls, whilst a study of 4 
subjects with congenital generalized lipodystrophy suggested that IMCL was higher (24). Using the CH2 
resonance, as is conventional in previous literature, we found soleus IMCL ‘content’ to be significantly 
higher in our LD subjects compared with controls (Table 1), demonstrating, we argue, the influence of 
composition on measures of concentration.  
The athlete’s paradox 
We found that the athletes’ IMCL was significantly lower (soleus) or similar (tibialis anterior) to controls. 
Although this appears to contradict well-known literature reports of an athlete’s paradox using both biopsy 
methods (13, 29, 34–36) and 1H MRS (37, 38), this finding is in agreement with literature that reports no 
such paradox compared to old or young controls (39), obese individuals (40), or in certain fibre types (14). 
It is known that athletes can have a large depletion-repletion range of IMCL and it is possible that IMCL 
had not fully recovered since the last training session (24 – 48 hrs prior) as IMCL can still rise 
significantly after these intervals (41). In fact, our results demonstrate an inverse relation of IMCL content 
and VO2max which is consistent with a study by Boesch et al. (42) where a combination of daily training at 
60% VO2peak with a low fat (10-15 % fat) diet depleted IMCL levels in both the vastus lateralis and 
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tibialis anterior muscles to a consistent level that correlated with VO2peak, suggesting that our female elite 
athletes were nearly ‘empty’ of IMCL; we did not control for diet in our study.  
Relationship of whole-body insulin resistance to IMCL  
Within the controls, only the compositional saturation index adjusted for quantity (CH2:CH3adj) in soleus 
was significantly correlated with whole-body insulin resistance (Table 2). The inclusion of insulin-
resistant lipodystrophic subjects increases the statistical significance of this relation and also yields 
associations with other composition-influenced markers, but not IMCL concentration in either muscle. In 
our study, the addition of athletes predictively reduced the associations with composition as their pools 
were small and therefore had a tendency for higher saturation index, but relations remain with measures 
that reflect large saturated pools (i.e. CH2:CH3adj and CH2). These striking results suggest that the 
accumulation of saturated IMCL and not concentration alone, relates to early-stage insulin resistance.  
Supporting our findings, the concentration of the most abundant saturated fat, palmitic acid, within muscle 
TG has been shown to be related to insulin sensitivity (43). Palmitic acid is known to increase ceramide 
concentrations, which are thought to engage stress-responsive serine kinases that impede insulin activation 
of its cell surface receptor, as well as downstream signalling molecules such as insulin receptor substrate 1 
(IRS-1) and Protein Kinase B/Akt (44). Our study was of course not able to probe these mechanisms. 
Limitations 
Unlike previous 1H MRS studies that have conventionally reported IMCL concentrations using the 
predominant CH2 resonance whilst assuming a notional normal composition, here we have utilized the 
smaller CH3 resonance, which has the advantage of composition-independence and, with comprehensive 
prior knowledge constraints including line-width constraints relative to the CH2 resonance (22), fitted the 
IMCL CH3 resonance from the overlapping EMCL/IMCL CH3 signals. Due to fibre orientation 
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differences between the soleus and tibialis anterior muscles the EMCL resonances are very slightly 
systematically shifted between muscle groups. Despite this potential for a systematic difference in the 
CH2:CH3 ratio between muscles, this ratio was still higher in the soleus compared to the tibialis anterior 
muscle in both EMCL-deficient AGLD subjects, consistent with findings in our other participants in this 
study and a previous study (17) suggesting a compositional difference between muscles. Our 
lipodystrophic subjects, who mainly had partial forms of lipodystrophy, had overall similar quantities of 
EMCL to those of our controls and athletes which has helped in reducing potential inter-group influence 
of this overlapping resonance. In addition, the relations of IMCL with HOMA-IR were robust to differing 
fitting routines including constraining the EMCL CH3 amplitude and accounting for asymmetric 
lineshapes. These, together with the finding that neither the IMCL CH2:CH3 or IMCL CH2:CH3adj markers 
related to either EMCL CH2 or CH3 suggests a lack of EMCL influence in our datasets; however, it is 
possible that in other insulin-resistant cohorts large overlapping EMCL resonances may be a confounding 
factor.   
Summary 
Use of our recently validated and potentially widely applicable 1H MRS approach to determine both the 
IMCL composition and concentration independent of composition within the soleus and tibialis anterior 
muscles of female individuals covering a wide range of insulin sensitivities has revealed that markers of 
the accumulation of saturated TG in the IMCL pool are more strongly associated with whole-body insulin 
resistance than IMCL concentration alone. Differences in associations of insulin resistance with IMCL 
concentration when using the CH3 and conventional CH2 peaks for quantification highlights the need for 
awareness of the potential influence of composition on previously-reported 1H MRS measures of 
concentration.  
Our finding of a strong relationship between VO2max and relatively unsaturated IMCL pools in controls 
and athletes points to a role of exercise in decreasing the amount of saturated fat within the IMCL store.. 
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The association of insulin resistance with the accumulation of saturated IMCL, even within a healthy 
control population, could suggest an early involvement in its pathogenesis and provide a reason why 
combined exercise and diet are effective therapeutic options in the early stages of insulin resistance. 
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Table 1. Characteristics of the participants, and ‘conventional’ muscle lipid estimates 
 
 Female  
LD         
n = 16 
Female 
controls        
n = 41 
Female 
athletes 
n = 14 
P value  
ANOV
A 
P value 
LD-
controls 
P value 
LD-
athletes 
P value 
controls
-athletes 
Age, yr 38.9±3.9 35.5±2.0 36.5±2.9 0.694    
BMI, kg.m-2 24.2±0.7 24.4±0.6 20.3±0.6 <0.001 0.999 0.001 <0.001 
Mass, kg 66.1±2.8 65.2±2.3 54.6±1.3 0.013 0.916 0.006 0.001 
Fat mass, kg 10.6±1.4 23.1±1.6 11.6±1.1 <0.001 0.001 0.631 <0.001 
FFM, kg 55.4±1.7 42.1±0.9 43.0±1.2 <0.001 <0.001 <0.001 0.705 
% body fat, % 16.1±1.7 34.2±1.2 21.1±1.8 <0.001 <0.001 0.129 <0.001 
Triglyceride, 
mmol/l 
3.54±0.67 0.92±0.07 a 0.84±0.08 <0.001 <0.001 <0.001 0.920 
HDL-cholesterol, 
mmol/l 
0.97±0.71 1.64±0.06 a 2.20±0.12 <0.001 <0.001 <0.001 0.001 
Glucose, mmol/l   6.00±0.58  4.56±0.06 a 4.46±0.13 <0.001 0.063 0.002 0.764 
Insulin, pmol/l     145.6±22.0  38.6±4.2 a 22.6±4.7 <0.001 <0.001 <0.001 0.025 
HOMA-IR 5.53±1.0 1.14±0.13 a 0.66±0.15 <0.001 <0.001 <0.001 0.025 
HbA1c, % 6.6±0.4 b ND 5.3±0.1 ND  0.008  
VO2max, ml.kg-
1.min-1 
ND 36.1±1.5 c 46.9±1.4 ND   <0.001 
Conventional IMCL, EMCL, expressed as CH2 /water-calc in units of %   
SOL IMCL  1.90±0.21 1.22±0.07 0.79±0.10 <0.001  0.027  <0.001 0.007 
TA IMCL  0.89±0.16 d 0.61±0.04 0.45±0.04 0.035 0.562 0.115 0.078 
SOL EMCL 2.05±0.34 2.22±0.19 1.81±0.20 0.493    
TA EMCL  1.43±0.28 d 2.30±0.19 1.24±0.15 0.002 0.163 0.785 0.005 
 
Non-normally distributed variables were log-transformed prior to performing ANOVA and Games-
Howell post hoc analysis; bold P values are statistically significant. Data presented are mean ± SEM. To 
convert insulin pmol/l to μU/ml divide by 6.945. FFM, fat free mass; ND, not done; IMCL, 
intramyocellular lipid; EMCL, extramyocellular lipid; SOL, soleus; TA, tibialis anterior; CH2, methylene 
protons resonating at 1.3 ppm quantified as a percentage of the uncorrected calculated water resonance.  
a n = 38, b n = 13, c n = 24, d n = 12.  
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Table 2. Correlation coefficients of whole-body insulin resistance with IMCL 
 
 
IMCL measure  HOMA-IR 
 Controls  
 
n = 38 
Controls and 
athletes 
n = 52 
Controls and 
LD 
n = 54 a 
Controls, LD and 
athletes       
 n = 68 b 
Soleus     
Concentration (CH3) -0.016 0.248 0.149  0.312* 
Concentration and composition (CH2) 0.153  0.315*    0.394**      0.477*** 
Composition (CH2:CH3) 0.217  -0.048      0.439***   0.241* 
Composition adjusted for quantity (CH2:CH3adj)  0.320*  0.271*      0.583***       0.532*** 
Tibialis Anterior     
Concentration (CH3) 0.200 0.251 0.205  0.258* 
Concentration and composition (CH2)   0.224 0.247   0.338*    0.344** 
Composition (CH2:CH3) 0.100 -0.046   0.337* 0.202 
Composition adjusted for quantity (CH2:CH3adj) 0.218 0.127       0.445***    0.364** 
 
* p < 0.05, ** p < 0.01, *** p ≤ 0.001 
Tibialis anterior has a n = 50 and b n = 64. 
HOMA-IR, Homeostasis Model Assessment of Insulin Resistance; IMCL, intramyocellular lipid; CH3, 
methyl protons resonating at 0.9 ppm; CH2, methylene protons resonating at 1.3 ppm; CH2:CH3, 
compositional saturation index calculated as the ratio of CH2 to CH3 resonances; CH2:CH3adj, CH2:CH3 
saturation index adjusted for lipid quantity. 
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Figure 1. The ratio of CH2:CH3 is influenced primarily by the degree of saturation of the fatty acids 
within triglyceride. This figure shows the principle of the CH2:CH3 ratio as a compositional saturation 
index of IMCL. (A) In this example palmitoleic acid component of triglyceride (TG) has a theoretical ratio 
of CH2 (at 1.3 ppm) to CH3 (at 0.9 ppm) of 16/3 = 5.3 which is lower than the equivalent ratio of palmitic 
acid = 8.0. This is due not only to the desaturation of two CH2 but also to the alteration in the chemical 
environment of the neighbouring CH2. For FA chains of equal number of double bonds, the CH2:CH3 ratio 
will also be scaled by chain length, although this will have a proportionally smaller effect (17). (B) 
Theoretical CH2:CH3 values for stearic, oleic, and linoleic fatty acids (FA) and approximate practical 
values, which are systematically shifted with respect to the theoretical values as discussed in (17). Part of 
this figure has been reproduced from (17) which is licensed under a Creative Commons Attribution 4.0 
International License.    
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Figure 2. Representative 1H MRS spectra from lipodystrophic (LD) subjects and an athlete. Water-
suppressed spectra from the soleus muscle of a subject with acquired generalised lipodystrophy (AGLD, 
upper left) and familial partial lipodystrophy (FPLD3, upper right); the absence of extramyocellular lipid 
(EMCL) in AGLD is highlighted by the vertical arrow. Spectra from an athlete’s soleus (lower left) and 
tibialis anterior (lower right) muscles illustrating the raw data (solid black) and overall fit (red dashed) and 
individual fit components (solid blue) in the frequency range that contains the EMCL CH2 (~ 1.5 ppm), 
CH3 (~1.1 ppm) and IMCL CH2 (1.3 ppm) and CH3 (0.9 ppm) resonances. The horizontal arrows 
highlights that the EMCL resonances are systematically shifted very slightly upfield in the soleus muscle 
compared with the tibialis anterior due to fibre orientation effects. The CH3 resonant frequencies are 
linked to the CH2 frequencies (solid bridge lines above spectra) and are also shifted. The fitting procedure 
fixes the relative CH2 to CH3 frequency shift for both EMCL and IMCL, and also fixes the CH3 linewidth 
relative to the corresponding CH2, but permits soft constraints on the CH2 frequencies.   
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Figure 3. Composition-independent concentrations of intramyocellular lipid in lipodystrophic 
subjects (green), controls (blue), and athletes (red). (A, B) Box and whisker plots showing Soleus 
(SOL) and tibialis anterior (TA) composition-independent IMCL concentration assessed from the 1H MRS 
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of methyl protons. (C, D) The relationship of soleus, tibialis anterior composition-independent IMCL 
concentration with VO2max in a subset of participants who underwent VO2max testing (controls: blue circles, 
n=24; athletes: red triangles, n=14). This was only significant when controls and athletes were combined, 
soleus (r = -0.52, p = 0.001) and tibialis anterior (r = -0.42, p = 0.009). (E, F) Soleus, tibialis anterior 
IMCL CH2 and CH3 components. The values are expressed relative to the calculated water signal (water-
calc), as described in ‘Methods’. The dotted line represents the linear regression line of the control data 
points.  * p<0.05, ** p<0.01, *** p <0.001. (A, B) tested by ANOVA and Games-Howell post hoc 
analysis, (C, D) by Pearson’s correlation coefficient.  
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Figure 4. 1H MRS measures of IMCL composition in lipodystrophic subjects (green), controls 
(blue), and athletes (red). (A - D) Box and whisker plots of (A) soleus (SOL) and (B) tibialis anterior 
(TA) IMCL compositional saturation index (CH2:CH3 ratio). (C, D) Soleus and tibialis anterior IMCL 
compositional saturation index adjusted for quantity. (E, F) Relation of soleus, tibialis anterior IMCL 
compositional adjusted saturation index with VO2max in the subset of participants who underwent VO2max 
testing (controls: blue circles, n=24; athletes: red triangles, n=14). Controls alone, significant correlation 
in the soleus (r = -0.546, p = 0.006) and tibialis anterior (r = -0.453, p = 0.026), athletes alone in the soleus 
(r = -0.558, p = 0.038), and with controls and athletes combined in soleus (r = -0.520, p = 0.001) and 
tibialis anterior (r = -0.362, p = 0.025). (G, H) Relation of HOMA-IR with soleus, tibialis anterior IMCL 
compositional adjusted saturation index. Correlation coefficients are shown in Table 2. * p<0.05, ** 
p<0.01, *** p <0.001. (A-D) tested by ANOVA and Games-Howell post hoc analysis, (E-F) by Pearson’s 
correlation coefficient.  
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